Exported to Myanmar (MG TNA-peri inj. 1920mL)  

Completed product registration in Syria (MG TNA inj., MG TNA-peri inj., Lipid LCT inj. 20%)  

Awarded 3 million dollars in exports by the government  

Acquired certificate of manufacturing for MGV inj.  

Contracted with Postbio Corp. for research development of allergen specific immunotherapy  

Awarded 1 million dollars in exports by the government  

Acquired certificate of manufacturing for Amino PN inj.  

Acquired business consulting support by MFDS for developing a patent strategy  

Acquired certificate of manufacturing for Pentacure inj.  

Acquired certificate of manufacturing for FOMS TNA inj. / FOMS TNA-peri inj.  

Completed product registration in Myanmar (MG TNA-peri inj. / Lipid LCT inj. 20%)  

Completed product registration in Philippines (MG TNA-peri inj.)  

Completed product registration in Philippines (Lipid LCT inj. 20%)  

Contracted with Vizcarra Pharmaceutical Corp. in Philippines for export  

Plant inspection of Kazakhstani MoH  

Designated as the hidden champion by Ministry of Employment and Labor (MOEL)  

Contracted with Wuhan Halfsky Pharmaceutical Corp. in China for export  

Acquired shares (36.83%) by Yuhan Corp.  

Acquired certificate of manufacturing for FOMS Lipid inj. 20%  

Contracted with CB Province for a site of Plant II (35,725㎡)  

Contracted with SNU R&DB Foundation for technology transfer of Lipid emulsion  

Obtained patents (sealing system of bag, etc)  

Designated as one of the top 100 companies in CB province  

Completed product registration in Vietnam (MG TNA/TNA-peri inj.)  

Contracted with Seoul Pharma for selling Aliver suspension  

Consignment production of high unit multivitamin, MG Vita-F tab.  

Exported to Vietnam (MG-TAN inj.)  

Completed product registration in Mongolia (MG TNA-peri inj. 960 ml etc.)  

Exported to Mongolia  

Acquired certificate of manufacturing for Amimix inj.  

Established MG R&D Center  

Plant inspection of Syrian MoH  

Contracted with Yuhan Corp. for exclusive selling of MG products (MG TNA-peri inj. 360 mI etc.)  

Contracted with Boryung Pharm. for consignment production (Amimix inj.)  

Designated as the Best Partner by the Korea Credit Guarantee Fund  

Consignment production of multivitamin, MG-Vita tab.  

Contracted with Dongsung Pharm. for selling Megetrol suspension  

Attracted investment from STIC Investment Inc.  

Completed 2nd floor extension of Gwanghyewon Plant  

Certified as the Venture Company  

Merged MG Co., Ltd. & MG Pharm Co.  

Contracted with Boryung Pharm. for production on commission  

Increased the capital to 5.2 billion won  

Registered MG COMBI as a trademark  

Produced Lipid LCT inj. for the first time in Korea as a non-PVC bag product  

Acquired certificate of manufacturing for Aminoglu inj.  

Acquired certificate of manufacturing for pharmaceutical products (KFDA)  

Acquired KGMP Qualification for the plant  

Produced MG TNA inj. for the first time in Korea  

Produced MG COMBI inj. 1  

Registered TNA as a trademark  

Started construction of KGMP plant in Gwanghyewon  

Established MG Pharm Co., which is designated as a KGSP company  

Contracted with Samsung Pharm. Ind. for production on commission  

Completed KGMP plant in Gwanghyewon  

Established MG Co.,Ltd. (capitalized at 6 hundred million won)